Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

42 results about "Isoamoenylin" patented technology

Icaritin K and preparation method thereof, and application of icaritin K to drugs

The invention relates to an extract of an epimedium plant, i.e., isopentenyl flavonoid with antineoplastic activity and as shown in a formula (I) which is described in the specification, a preparationmethod thereof, a pharmaceutical composition with the isopentenyl flavonoid as shown in the formula (I) as an active component and for treating and preventing tumors, and application of the isopentenyl flavonoid and the pharmaceutical composition to preparation of drugs used for treating and preventing tumors.
Owner:YUNNAN BIOBIAOPHA TECH

Truncated sophora flavescens isopentenyl transferase and application thereof

The invention discloses truncated sophora flavescens isopentenyl transferase and application thereof, and belongs to the field of bioengineering. On the basis of isopentenyl transferase SfN8DT-1 from sophora flavescens, truncation of different sites is respectively carried out on an N terminal, and a recombinant plasmid pY26-SfN8DT-1 and seven truncated isopentenyl transferase mutant plasmids are constructed. The recombinant plasmid is transferred into saccharomyces cerevisiae to obtain a recombinant saccharomyces cerevisiae strain for denovo synthesis of 8-isopentenyl naringenin. The recombinant saccharomyces cerevisiae can produce 9.33 mg / L of the 8-isopentenyl naringenin at most after being fermented in a YPD culture medium for 120 hours, the yield is improved by 290.10% compared with that of a control strain PN01-pY26-SfN8DT-1, and the yield of the 8-isopentenyl naringenin is the highest among currently reported yields of biosynthesized 8-isopentenyl naringenin. The strategy lays a foundation for producing the 8-isopentenyl naringenin by transforming the saccharomyces cerevisiae through metabolic engineering.
Owner:JIANGNAN UNIV

The method of extracting 5-isopentenyl herbalin from water chestnut skin

The invention relates to a method for extracting 5-isopentenyl aureusidin from eleocharis tuberose peels and belongs to the field of natural organic chemistry. The method is characterized by comprising the following steps of as an aqueous solution of acetone is used as a solvent, extracting the 5-isopentenyl aureusidin from the eleocharis tuberose peels to obtain an extract, extracting the extract with ethyl acetate to obtain an extractant, separating the extractant with a medium-pressure MCI column chromatography and a polyamide column chromatography to obtain a matter and repeatedly purifying the matter with a Sephadex LH-20 gel chromatography to obtain a 5-isopentenyl aureusidin product of which the content of the 5-isopentenyl aureusidin is above 95%. According to the method, a novel way for extracting and separating the 5-isopentenyl aureusidin from natural plants is created, the good separation effect is achieved, the product is high in purity, the eleocharis tuberose peels always regarded as wastes are changed into treasure, chromatographic materials, namely, MCI, polyamide and sol, can be repeatedly used, and the method has the advantages that raw materials are easily available, resources are abundant and the production cost is low; the product can be subjected to large-scale production and meets the needs of pharmaceutical industry.
Owner:HEZHOU UNIV

Isopentenyl substituted coumarin compound and preparation method and application thereof

The invention relates to the field of natural medicines, and discloses an isopentenyl-substituted coumarin compound which is derived from artocarpus heterophyllus and has a novel chemical structure, a preparation method of the isopentenyl-substituted coumarin compound and application of the isopentenyl-substituted coumarin compound in anti-tumor medicines, and various in-vitro anti-tumor activity evaluation results of the compound artoheterronin show that the compound has remarkable anti-tumor activity, has the protein tyrosine kinase inhibition activity equivalent to that of a positive control drug, can be further developed into an anti-tumor drug taking protein tyrosine kinase as a target, can be applied to the anti-tumor drug, is simple in separation and purification process and mild in reaction condition, and has practical significance.
Owner:HAINAN NORMAL UNIVERSITY

Recombinant strain containing enol kinase gene and isopentenyl phosphokinase gene and application of recombinant strain in terpenoid production

The invention discloses a recombinant strain containing an enol kinase gene and an isopentenyl phosphokinase gene and application of the recombinant strain in terpenoid production. The recombinant strain comprises an enol kinase gene and an isopentenyl phosphokinase gene, and preferably, the recombinant strain is selected from saccharomycetes or escherichia coli. The invention also discloses a recombinant plasmid containing an enol kinase gene and an isopentenyl phosphokinase gene, a construction method of the recombinant plasmid, and a method for producing terpenoids by using the recombinant strain. The gene is constructed on a shuttle plasmid or integrated on a genome to express enol kinase and isopentenyl phosphokinase in recombinant bacteria, and isopentenyl pyrophosphoric acid and dimethyl allyl pyrophosphoric acid are produced by taking enol as a substrate to participate in synthesis of terpenoids. According to the approach, only two-step reaction and participation of a cofactor (ATP) are needed, and the approach is separated from central carbon metabolism; according to the invention, the biosynthesis process of the terpenoids has stronger metabolic flux, and the yield of the terpenoids is improved.
Owner:SHENZHEN INST OF ADVANCED TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products